Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Assets: 2021-2024

Historic Assets for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to $297.5 million.

  • Prime Medicine's Assets rose 15.69% to $385.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $385.0 million, marking a year-over-year increase of 15.69%. This contributed to the annual value of $297.5 million for FY2024, which is 53.47% up from last year.
  • Prime Medicine's Assets amounted to $297.5 million in FY2024, which was up 53.47% from $193.9 million recorded in FY2023.
  • In the past 5 years, Prime Medicine's Assets registered a high of $360.3 million during FY2022, and its lowest value of $193.9 million during FY2023.
  • For the 3-year period, Prime Medicine's Assets averaged around $283.9 million, with its median value being $297.5 million (2024).
  • In the last 5 years, Prime Medicine's Assets crashed by 46.20% in 2023 and then skyrocketed by 53.47% in 2024.
  • Prime Medicine's Assets (Yearly) stood at $301.9 million in 2021, then grew by 19.37% to $360.3 million in 2022, then slumped by 46.20% to $193.9 million in 2023, then soared by 53.47% to $297.5 million in 2024.